Blog: Our Insights
Your resource for industry news and updates from Broughton.

Yvonne Wilding

Yvonne Wilding is the Director of Product Safety and Compliance. She has over 10 years of broad regulatory toxicology experience and 20 years of pharmaceutical drug development Research & Development leadership. She has been responsible for numerous MAA and NDA submissions, for both small molecules and biologics and has experience stretching from early candidate selection through life cycle management of new medicines. Her toxicology experience was gained with GlaxoSmithKline's (GSK) large portfolio of respiratory products in a specialized inhalation toxicology department. Yvonne began her career as a regulatory toxicologist for GSK responsible for designing the strategic drug safety evaluation programs to satisfy all global markets using both in-vivo and in-vitro approaches; for operational delivery both with an in-house team and with Contract Research Organisations (CRO). This involved working closely with clinical teams and key opinion leaders to ensure patient safety at each stage of development. She has extensive experience of interacting with regulatory agencies. Following on from Toxicology, Yvonne was responsible for managing and leading drug development programs encompassing all functional disciplines to ensure delivery of successful marketing applications and to maximise the commercial opportunity for each product. Yvonne’s clinical experience encompasses clinical program strategy, study management, clinical portfolio management and pharmacovigilance. Most recently, Yvonne worked with AstraZeneca in the Precision Medicine department to develop new diagnostic tests and submit PMA applications for companion diagnostics devices evaluating genetic biomarkers of disease susceptibility in collaboration with major diagnostic companies.

Recent Posts

We’ve officially left the EU, but what does ...

May 13, 2021

Broughton Director of Product Safety and Compliance, Yvonne Wilding, discusses implications of Brexit on the international ENDS market. 

ToxHQ System For Product Formulation

January 20, 2021

Broughton Director of Product Safety and Compliance, Yvonne Wilding, discusses a leading-edge software tool designed and in use at ...

Join us at the American College of Toxicology ...

November 12, 2020

Broughton, Director of Product Safety and Compliance, Yvonne Wilding and Principal Scientist, Louise Neilson will be in attendance and ...

What does the new TPPI guidance mean to ENDS ...

November 6, 2020

Broughton Director of Product Safety and Compliance, Yvonne Wilding, looks at the recent Tobacco Product Perception and Intention studies ...

Post Market Requirements - A journey, not a ...

October 16, 2020

Broughton , Director of Product Safety and Compliance, Yvonne Wilding has recently published an article with leading sector publication ...

Blog: Safety Evaluation of Extractables and ...

July 23, 2020

Broughton announce new webinar.

What is Toxicology for ENDS

May 19, 2020

This article provides an overview of the different types of toxicological studies typically undertaken, and how they support regulatory ...
Contact us

From basic questions to complex compliance inquiries, we're here to help! Contact us today.